Model AZD8630 - Phase I - Asthma

Mechanism: Inhaled TSLP Fab. Area under investigation: asthma. Date commenced phase: Q1 2022. Estimated Filing Acceptance: Country US:EU: Japan: China: Additional information: Partnered product. Molecule size: Large molecule. Status change: